Q2 2018 Holdings
Filed 2018-08-14 | 36 holdings | $108.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axogen Inc(AXGN) | COM | 05463X106 | $72.4M | 1,440,000 | 66.5% |
| Codexis Inc(CDXS) | COM | 192005106 | $25.2M | 1,750,000 | 23.2% |
| Agios Pharmaceuticals(AGIO) | COM | 00847X104 | $10.9M | 130,000 | 10.1% |
| Loxo Oncology | COM | 548862101 | $30.4K | 175,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $22.5K | 360,000 | 0.0% |
| Blueprint Medicines(2L9) | COM | 09627Y109 | $22.2K | 350,000 | 0.0% |
| Polarityte Inc | COM | 731094108 | $18.8K | 800,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $16.5K | 420,000 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $11.4K | 1,200,000 | 0.0% |
| Strongbridge Biopharma PLC | COM | G85347105 | $11.0K | 1,830,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | COM | 31447P100 | $9.9K | 945,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $9.4K | 697,500 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $8.2K | 625,000 | 0.0% |
| Amag Pharmaceuticals Inc(AMAG) | COM | 00163U106 | $8.2K | 420,000 | 0.0% |
| Miragen Therapeutics Inc | COM | 60463E103 | $7.7K | 1,200,000 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $7.5K | 1,111,000 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $7.4K | 550,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $7.3K | 190,000 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $7.2K | 505,000 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $6.7K | 320,200 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $6.7K | 180,000 | 0.0% |
| Corium International Inc | COM | 21887L107 | $6.4K | 800,000 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $6.2K | 1,200,000 | 0.0% |
| Ultragenyx Pharmaceuticals Inc(RARE) | COM | 90400D108 | $6.1K | 80,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $6.1K | 180,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $5.8K | 265,000 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $5.5K | 1,150,000 | 0.0% |
| Amarin Corp PLC | SPONSORED ADR | 023111206 | $5.4K | 1,750,000 | 0.0% |
| Biofrontera AG | SPONSORED ADR | 09075G105 | $4.8K | 391,400 | 0.0% |
| GTX Inc | SHS | M46135105 | $3.8K | 250,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $3.7K | 275,000 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $2.3K | 420,000 | 0.0% |
| Protalix Biotherapeutics Inc | COM | 74365A101 | $1.3K | 3,100,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $803 | 161,400 | 0.0% |
| Azurrx Biopharma Inc | COM | 05502L105 | $417 | 130,000 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $222 | 250,000 | 0.0% |